Multiple Sclerosis

Teva buying Auspex for $3.2 billion

Teva Pharmaceutical Industries Ltd. is buying Auspex Pharmaceuticals Inc. for about $3.2 billion in a move to strengthen its position on central nervous system condition treatments.

Mar 30, 2015
popularity 3 comments 0

Researchers develop database on healthy immune system

An extensive database identifying immune traits, such as how immune cell function is regulated at the genetic level in healthy people, is reported by researchers from the National Institutes of Health (NIH) and their collaborators ...

Mar 12, 2015
popularity 3 comments 0

Latest Spotlight News

Longer acquaintance levels the romantic playing field

Partners who become romantically involved soon after meeting tend to be more similar in physical attractiveness than partners who get together after knowing each other for a while, according to new findings ...

First-ever possible treatments for MERS

As the South Korean epidemic of Middle East Respiratory Syndrome (MERS) continues unabated, researchers have raced to find treatments for the deadly virus, which has killed more than 400 people since it was ...